Browse investments

Invest in Arcutis Biotherapeutics Inc on Stash

Arcutis Biotherapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases.

To buy fractional shares of Arcutis Biotherapeutics Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Ticker: ARQT

Arcutis Biotherapeutics Inc

$29.51

+5.36%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

ARQT Performance Breakdown

Share Price

$29.51

Today's change

5.09%

Year to date change (YTD)

102.68%

Dividend yield

0.0

Last dividend paid

N/A

Last dividend pay date

N/A

About ARQT

Arcutis Biotherapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases. Its portfolio is comprised of topical treatments with potential to address immune-mediated dermatological diseases and conditions, or immuno-dermatology. Its strategy is to identify and develop treatments against validated biological targets in dermatology that deliver a differentiated clinical profile that addresses major shortcomings of existing therapies in targeted indications. Its products pipelines include ARQ-151, ARQ-154, ARQ-252 and ARQ-255.

Arcutis Biotherapeutics Inc Stock Ticker

ARQT

For more information

https://www.arcutis.com

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Invest in Arcutis Biotherapeutics Inc on Stash

Arcutis Biotherapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases.

To buy fractional shares of Arcutis Biotherapeutics Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Certain companies are volatile

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Arcutis Biotherapeutics Inc stock news

CNBC

How $160 million worth of export-controlled Nvidia chips were allegedly smuggled into China

On Dec. 8, Federal prosecutors in Texas unsealed documents that revealed they had shut down a China-linked smuggling network for export-controlled Nvidia H100 and H200 GPUs. The smuggling ring, they said, attempted to export at least $160 million worth of Nvidia AI chips between October 2024 and May 2025.

about 8 hours ago

24/7 Wall Street

Netflix (NASDAQ: NFLX) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Netflix Inc. (NASDAQ: NFLX) has had a lot to celebrate in 2025, including the final season of popular show “Stranger Things” and movies Frankenstein and Wake Up Dead Man; the success of international content from Korea, Latin America, and elsewhere; and the introduction of live and interactive content.

about 6 hours ago

Business Insider

Tesla just made an 'unusual' move, and it could mean a rough end to the year

Tesla published analyst estimates ahead of releasing critical sales figures this week. It was a surprise move for Elon Musk's EV maker, with one former investor calling it "highly unusual.

about 9 hours ago

CNBC

'Big Short' investor Michael Burry says he's not shorting Tesla

Michael Burry, the investor made famous for calling the housing crash before 2008, has denied shorting Tesla's shares. It comes shortly after the "The Big Short" investor doubled down on his view that the carmaker's market capitalization is "ridiculously overvalued.

about 9 hours ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.^†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,⁸ recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.¹

Learn how to invest

Get professional advice and education at every step.

How to buy Arcutis Biotherapeutics Inc stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Arcutis Biotherapeutics Inc’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Arcutis Biotherapeutics Inc’s price can fluctuate throughout the course of each trading day—when you buy Arcutis Biotherapeutics Inc through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Arcutis Biotherapeutics Inc stock price and the Arcutis Biotherapeutics Inc news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers two subscription plans: Stash Growth and Stash+.

Each plan can help you reach different goals and offers a unique combination of financial accounts and features. All plans include access to a personal brokerage account—also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Arcutis Biotherapeutics Inc stock is complete, you'll officially be a shareholder of Arcutis Biotherapeutics Inc!